In his new book, “Phake: The Deadly World of Falsified and Substandard Medicines,” Roger Bate explores the underground trade in illegal medicines that kills over 100,000 people per year and supplants billions of dollars of real products.

Knowing where all our ingredients come from is the first step toward improving drug quality.

Policymakers concerned with rising drug prices must consider the cost of regulating pharmaceutical prices.

This book explains why efforts to control drug prices through political means are deeply misconceived and could thwart today's dramatic improvements in health.

Pharmaceutical price controls have become a controversial political issue. Numerous federal and state legislators have proposed reducing pharmaceutical prices by various methods. President Clinton's proposed out-patient drug benefit for Medicare-with special mechanisms for negotiating drug prices--is expected to be one of the high-visibility legislative proposals Congress considers in this election...

Price controls on prescription medicines could constrain research and impair the development of new drugs, according to a newAEI study.

Murray Aitken, vice president of IMS Health, the world's largest source of drug-price and sales data, and MIT professor Ernst Berndt will explain why their research shows that average drug prices for seniors have declined, not increased, by more than 20 percent.

3.8 percent of drugs sampled from countries with emerging economies failed basic quality control tests--and these drugs are used to treat potentially lethal infections. Africa has a greater problem with substandard products than any other location.